/Companies

株式会社メドレックス

2 known investors

Find your way into 株式会社メドレックス

Sign up to find every way you can get introduced to 株式会社メドレックス

  • Your email: who you already know at 株式会社メドレックス, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the 株式会社メドレックス team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

MedRx is a Japanese pharmaceutical company developing new drugs based on transdermal delivery technologies such as its ILTS and NCTS platforms and microneedle arrays. It is a publicly listed company focused on creating novel therapeutics for patients with various diseases.

Founders & leadership

YM
Yonehiro MatsumuraRepresentative Director & President

Investors · 2

Frequently asked questions

What does 株式会社メドレックス do?
MedRx is a Japanese pharmaceutical company developing new drugs based on transdermal delivery technologies such as its ILTS and NCTS platforms and microneedle arrays. It is a publicly listed company focused on creating novel therapeutics for patients with various diseases.
Who are 株式会社メドレックス's investors?
株式会社メドレックス's investors include Nippon Venture Capital, SMBC Venture Capital.